by maixaule | Oct 16, 2026 | Blog
GMP certificates for manufacturing sites abroad: what ANMAT Disposition 6403/26 changes On October 6, ANMAT, Argentina’s health authority, published Disposition 6403/2026in the Official Gazette. It sets out how Good Manufacturing Practice (GMP) certificates are...
by maixaule | Aug 27, 2026 | Blog
Argentina Approves MERCOSUR–Singapore Trade Agreement: A New Step Towards Asia and Latin America Market Access Argentina has taken an important step towards strengthening its international trade relations, with Congress approving the MERCOSUR–Singapore Free Trade...
by maixaule | Feb 28, 2026 | Blog
Regulatory and Commercial Impact Analysis of ANMAT Regulations 2025–2026 1. GENERAL CONTEXT OF REGULATORY CHANGES Strategic Orientation The regulations issued by ANMAT between October 2025 and February 2026 respond to a clear strategy of modernization and...
by maixaule | Feb 26, 2026 | Blog
Introduction: A Wind of Change in Health Regulation In recent months, Argentina’s National Administration of Drugs, Foods, and Medical Technology (ANMAT) has driven a series of regulatory reforms that redefine the landscape for the import, manufacture, and...
by maixaule | Dec 29, 2025 | Blog
ANMAT Disposition 7516/2025: A Regulatory Milestone Transforming Clinical Research and Pharmacovigilance in Argentina December 1st marked a turning point in the Argentine pharmaceutical regulatory landscape. With the entry into force of ANMAT Disposition 7516/2025,...
by Analia Katriniuk | Oct 28, 2025 | Blog
Healthcare in Latin America is evolving rapidly in 2025. From digital transformation and regulatory modernization to supply chain optimization and patient-centered care, the region is embracing innovations that improve access, quality, and efficiency. While artificial...
